Treatment of chemotherapy-induced anemia in breast cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40,000 U weekly.

Source:http://linkedlifedata.com/resource/pubmed/id/16381629

Download in:

View as

General Info

PMID
16381629